“Training of doctors today is a major issue worldwide” Dr Ashish V. Rawandale-Patil, Director, Tejnaksh Healthcare
Since its inception in 2008, Dr Ashish RawandalePatil, director, Tejnaksh Healthcare, has taken the company from a small urology hospital to a multicity, multispecialty, multifaceted healthcare chain. Known for his tough business decisions and the urge to challenge the status quo, he has multiple credentials up his belt. BioSpectrum spoke to him about the company’s plans to offer affordable healthcare system to rural population. Edited excerpts;
Are there any further acquisitions planned?
We are aiming to add 70 to 100 beds per year and we are actively looking for opportunities take over more hospitals.
How much revenue is Tejnaksh Healthcare making currently? How will these acquisitions help in boosting the revenue of the organization?
Tejnaksh has recently declared its results, Revenues for FY18 was at Rs 14.84 crore, registered a growth of 98.67 per cent, PAT was at Rs 3.22 crore, grown by 68.59 per cent. The recent acquisitions have helped in increasing our presence and bed count in multiple cities and also our brand presence. As we have adopted lease model the profitability would be higher as compared to acquiring hospitals on outright basis, where in capex requirement is high and break even time is long.
What are the challenges that you have faced in taking the company from a small urology hospital to a multicity, multispecialty, multifaceted healthcare chain?
We have not experienced any major hurdles in our growth path. However, the healthcare sector is capital intensive with large investment in to buildings and equipment. At the current interest rates achieving the breakeven point for a hospital is takes longer. Hence at present we have adopted the model of leasing hospitals. Even Tejnaksh needs more capital to grow in the next couple of years.
Tell us about Uroinnovation Foundation established by you and how it has helped doctors in doing innovations.
India has big talent in medical field and many innovations have not reached the level of commercial production. Uroinnovation Foundation has been started to bring out ideas of leading doctors in the country and taking them up to commercial production and launching stage in the market. We have made good progress on this front and many doctors have joined this foundation and we are jointly working with shared intellectual property rights with these scientists and moving towards getting these ideas to the commercial platform.
What steps have you taken to ensure provision of affordable healthcare system in India?
Tejnaksh Healthcare is continuously creating innovative technology with its research work. We are modifying the administrative ways and also trying to increase the clinical productivity using various strategic decisions.
Training of doctors today is a major issue worldwide as ethical constraints restrict new doctor to train on patients. Tejnaksh has struck the very roots of it and has successfully commenced its patented simulation program with indigenously manufactured patented simulators. PCNL Simulator is an artificial body created for the extraction of kidney stones from the body of a patient. This is used for stone extraction practice for budding urologists. Tejnaksh simulators allow economical training of the young doctors. At present 5 PANG PERC System, Fluoroscopy Free Simulator, Dilation Bench, Puncture logic bench, USG guided Simulator, Fluoroscopy Guided Simulator, Portable Fluoroscopy Simulator are being manufactured and being used for training. Our instruments are developed in India, and proving to be a small step towards affordable healthcare in the country.
Tejnaksh continues to fathom newer avenues, breakthrough newer achievements and is reaching newer heights. Quality healthcare at an affordable cost, strategy innovations, healthcare instrumentation and innovations, simulation labs and related education hubs is now what Tejnaksh is looking forward to in the future.
Dr Ashish V. Rawandale-Patil, Director, Tejnaksh Healthcare